Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia

Widiasari, Ni Putu Ayu; Rai, Ida Bagus Ngurah; Dwi Kusumawardani, Ida Ayu Jasminarti; Sajinadiyasa, I Gede Ketut; Candrawati, Ni Wayan; Arisanti, Ni Luh Putu Eka

doi:10.2478/rjim-2022-0020

.blurhash-client-img { display: none !important; }

Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia

Romanian Journal of Internal Medicine

Volume 61 (2023): Issue 1 (March 2023)

By: Ni Putu Ayu Widiasari, Ida Bagus Ngurah Rai, Ida Ayu Jasminarti Dwi Kusumawardani, I Gede Ketut Sajinadiyasa, Ni Wayan Candrawati and Ni Luh Putu Eka Arisanti

Open Access

|Mar 2023

Authors

Ni Putu Ayu Widiasari

ayu.widiasari@yahoo.com

Pulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, Indonesia

Ida Bagus Ngurah Rai

Pulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, Indonesia

Ida Ayu Jasminarti Dwi Kusumawardani

Pulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, Indonesia

I Gede Ketut Sajinadiyasa

Pulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, Indonesia

Ni Wayan Candrawati

Pulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, Indonesia

Ni Luh Putu Eka Arisanti

Pulmonology and Respiratory Medicine, Faculty of Medicine Udayana University/Prof IGNG Ngoerah General Hospital, Denpasar, Indonesia

DOI: https://doi.org/10.2478/rjim-2022-0020 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749

Journal RSS Feed

Language: English

Page range: 63 - 71

Submitted on: Oct 1, 2022

Published on: Mar 16, 2023

Published by: N.G. Lupu Internal Medicine Foundation

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

adenocarcinoma,

EGFR,

Neutrophil-to-Lymphocyte Ratio,

Tyrosine Kinase Inhibitor,

Progression Free Survival

Related subjects:

Medicine,

Clinical medicine,

Internal medicine,

Internal medicine, other,

Cardiology,

Gastroenterology,

Rheumatology

© 2023 Ni Putu Ayu Widiasari, Ida Bagus Ngurah Rai, Ida Ayu Jasminarti Dwi Kusumawardani, I Gede Ketut Sajinadiyasa, Ni Wayan Candrawati, Ni Luh Putu Eka Arisanti, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 61 (2023): Issue 1 (March 2023)